Pre-pulse inhibition is altered in patients with schizophrenia and modulation of catecholamine neurotransmission, especially that of dopamine, is used to treat schizophrenia, suggesting that PDXDC1 is an important gene to examine in future studies, especially in iPSC-derived catecholaminergic neurons. This evidence concerns the gene PDXDC1 and schizophrenia.